#notstarted
ME 3.15.1.1(a)
Aetiology and pathophysiology of infectious diseases, including: Antibiotic use in the ED
ME 3.15.1.1(b)
Aetiology and pathophysiology of infectious diseases, including: Systemic inflammatory response syndrome
ME 3.15.1.1(c)
Aetiology and pathophysiology of infectious diseases, including: Sepsis, septic shock
ME 3.15.1.1(d)
Aetiology and pathophysiology of infectious diseases, including: Multiple organ dysfunction
ME 3.15.1.1(e)
Aetiology and pathophysiology of infectious diseases, including: Toxic shock syndrome
ME 3.15.1.1(f)
Aetiology and pathophysiology of infectious diseases, including: Infections in the returned traveller, including:
ME 3.15.1.1(g)
Aetiology and pathophysiology of infectious diseases, including: Malaria
ME 3.15.1.1(h)
Aetiology and pathophysiology of infectious diseases, including: Dengue fever
ME 3.15.1.1(i)
Aetiology and pathophysiology of infectious diseases, including: Haemorrhagic fevers
ME 3.15.1.1(j)
Aetiology and pathophysiology of infectious diseases, including: Typhoid
ME 3.15.1.1(k)
Aetiology and pathophysiology of infectious diseases, including: Zika virus
ME 3.15.1.1(l)
Aetiology and pathophysiology of infectious diseases, including: Viral infections, including:
ME 3.15.1.1(m)
Aetiology and pathophysiology of infectious diseases, including: HIV
ME 3.15.1.1(n)
Aetiology and pathophysiology of infectious diseases, including: Infectious mononucleosis
ME 3.15.1.1(o)
Aetiology and pathophysiology of infectious diseases, including: Influenza/parainfluenza
ME 3.15.1.1(p)
Aetiology and pathophysiology of infectious diseases, including: Herpes simplex
ME 3.15.1.1(q)
Aetiology and pathophysiology of infectious diseases, including: Herpes zoster
ME 3.15.1.1(r)
Aetiology and pathophysiology of infectious diseases, including: Rheumatic fever, including:
ME 3.15.1.2(a)
Complications and long-term sequelae prevalence in at-risk populations Antibiotic prophylaxis for sore throat
ME 3.15.1.2(b)
Complications and long-term sequelae prevalence in at-risk populations Treatment protocols for high-risk groups
ME 3.15.1.2(c)
Complications and long-term sequelae prevalence in at-risk populations Mycoplasma infections
ME 3.15.1.2(d)
Complications and long-term sequelae prevalence in at-risk populations Fungal infections
ME 3.15.1.2(e)
Complications and long-term sequelae prevalence in at-risk populations Protozoal infections
ME 3.15.1.2(f)
Complications and long-term sequelae prevalence in at-risk populations Tick-borne infections
ME 3.15.1.3
ME 3.15.1.4
Principles of infection control in the ED.
ME 3.15.1.5
Standard precautions in the ED for protection of staff from infectious disease.
ME 3.15.1.6
Standard protocols for the management of suspected exposure of staff to infectious disease.
ME 3.15.1.7
Principles of management of infectious disease outbreaks, including surveillance protocols.
ME 3.15.1.8
Reportable communicable diseases and protocols for reporting.
ME 3.15.1.9
Take a history and perform a targeted examination of a patient with a suspected infectious disease.
ME 3.15.2.1
Aetiology and pathophysiology of fever in the infant patient with bacteraemia.
ME 3.15.2.2(a)
Aetiology and pathophysiology of: Bacterial infections, including:
ME 3.15.2.2(b)
Sexually transmitted infections
ME 3.15.2.2(c)
Infection from marine source
ME 3.15.2.2(d)
Secondary bacterial infections in the burns patient
ME 3.15.2.3
Interpret symptoms and clinical signs of infectious disease.
ME 3.15.2.4
Interpret relevant investigations as per the investigations list.
ME 3.15.2.5
Generate a differential diagnosis, plan of treatment and disposition for patients with suspected infectious disease.